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1078–5884/00Meta-analysis of the Clinical Effectiveness of Venous
Arterialization for Salvage of Critically Ischaemic Limbs
X.W. Lu,1 M.M. Idu,1 D.T. Ubbink1,2 and D.A. Legemate1*Departments of 1Surgery, and 2Clinical Epidemiology and Biostatistics, Academic Medical Center,
Amsterdam, The NetherlandsObjective. The aim of this study is to assess the clinical effectiveness of venous arterialization in patients with critical limb
ischaemia not reconstructable by conventional bypass.
Design. Meta-analysis of observational studies.
Materials. Eligible studies concerning treatment by venous arterialization for chronic critical leg ischaemia were identified
from electronic database, cross-reference search and pertinent articles. There was no language restriction.
Methods. All relevant studies were systematically reviewed and data extracted by two independent reviewers. Study
endpoints were foot preservation, secondary graft patency, postoperative clinical improvement and complications.
Results. A total of 56 studies were selected for comprehensive review. No RCTs were identified. Seven patient series,
comprising 228 patients, matched the selection criteria. Overall 1-year foot preservation was 71% (95% CI: 64–77%) and
1-year secondary patency was 46% (95% CI: 39–53%). The large majority of patients in whom major amputation was
avoided experienced successful wound healing, disappearance of rest pain and absence of serious complications.
Conclusion. On the basis of limited evidence, venous arterialization may be considered as a viable alternative before major
amputation is undertaken in patients with ‘inoperable’ chronic critical leg ischaemia.Keywords: Limb salvage; Lower extremity; Leg ulcer; Arteriovenous shunt; Review.Introduction
As the average age of the population continues to
increase, a concomitant rise in significant peripheral
vascular disease is anticipated. Despite advances in
surgical and interventional radiological techniques, a
substantial number of patients with critical limb
ischaemia cannot be treated by any conventional
therapeutic procedure and require amputation. It has
been estimated that between 14 and 20% of patients
with critical lower-limb ischaemia (CLI; gangrene,
ulceration, severe pain at rest or a combination of
these) are not suitable candidates for distal arterial
reconstruction because of extensive occlusion of the
crural and pedal vessels.1,2 Alternative treatment
options, for example prostaglandin treatment or
spinal cord stimulation, have been proposed foring author. Prof Dr D.A. Legemate, MD, PhD,
of Surgery, G4-111, Academic Medical Center, P.O.
00 DE Amsterdam, The Netherlands.
: d.a.legemate@amc.nl
0493+ 07 $35.00/0 q 2006 Published by Elsevier Ltd.these inoperable cases, but with limited clinical
effectiveness and applicability.3,4 Hence, most
patients with inoperable CLI will eventually face a
major amputation. The outlook for these patients is
poor. Major amputation is linked with substantial
morbidity and mortality, with a particularly high
prevalence of cardiopulmonary disease.1,2 Thus,
amputation is not an easy option and there is a
strong case for attempting any procedure to save the
affected limb.
Another possible option to relieve CLI is venous
arterialization of the lower leg. The concept of using
the disease-free venous bed as an alternative conduit
for perfusion of the peripheral tissues with arterial
blood was first published by Halstead and Vaughan in
1912.5 In theory there are several reasons why venous
arterialization might benefit patients. One is that
reversal of flow all the way through the capillaries
improves tissue nutrition.6,7 Another is that flow in
existing collateral vessels will increase.7,8 The third is
stimulation of angiogenesis.7–10Eur J Vasc Endovasc Surg 31, 493–499 (2006)
doi:10.1016/j.ejvs.2005.12.017, available online at http://www.sciencedirect.com on
X. W. Lu et al.494Over the years, several studies concerning venous
arterialization have been published. Some of these
report encouraging clinical outcomes,11–26 whereas
others reported rather pessimistic conclusions.27–29 It
has been questioned whether venous arterialization
relieves critical ischaemia and prevents amputation.
The aim of this study was to systematically review the
literature on the clinical effectiveness of venous
arterialization for lower limb salvage in patients who
could not be revascularised with conventional
methods.Material and MethodsCriteria for inclusion
Eligible articles had to meet the following criteria: (1)
they should describe patients with CLI unsuited for
distal arterial reconstruction, and should include a
minimum of ten patients; (2) patients had to be treated
by venous arterialization, including various operative
options, such as staged arteriovenous reversal, distal
venous arterialization, etc.; (3) the period of follow-up
should be longer than 12 months; (4) the primary
outcome measure had to be foot preservation (FP) or
limb salvage, which ended at themoment a major (foot
or higher) amputation took place; secondary outcome
measures were primary or secondary graft patency
rates, pain relief, wound healing, complications and
mortality; (5) it should be an original patient series
(studies containing duplicate material were excluded
and the ones with the best documented material were
included for analysis); (6) types of studies: clinical
studies including observational studies or case
reports. These criteria complied with the recommen-
dation of broad inclusiveness for meta-analysis of
observational studies.30 The free text andMeSH search
terms used were: ‘ischaemia’, ‘lower extremity’,
‘venous arterialization’, ‘arteriovenous reversal’,
‘arteriovenous fistula’ and ‘lower limb salvage’. The
search was not limited by language.
Chronic CLI was defined according to the transat-
lantic inter-society consensus document (TASC 2000),
which is based on the clinical symptoms predomi-
nantly caused by peripheral arterial disease (i.e.
ischaemic rest pain and/or ulceration).31 Milder
forms of leg ischaemia, in particular intermittent
claudication, were not considered suitable conditions
for venous arterialization because this condition does
not generally require vascular reconstruction.
‘Inoperable’ was defined as the situation in which
the treating physician identified no surgical optionsEur J Vasc Endovasc Surg Vol 31, May 2006for the patient to treat the critically ischaemic leg by
conventional arterial revascularisation. This occurs
when no crural arteries can be found on the
angiogram, duplex scan or MR angiography as
potential sites for a distal bypass procedure.
Venous arterialization was defined as the use of the
disease-free venous bed as an alternative conduit for
perfusion of the peripheral tissues with arterial blood.
Primary patency was defined as uninterrupted
patency with no procedure performed on the conduit
as determined by clinical examination, measurement
of ABPI, duplex ultrasonography, or angiography.
Secondary patency (SP) was the patency after restor-
ing an occlusion or after a procedure to protect the
conduit from occluding.Study identification
A systematic search of the literature was conducted by
searching the following databases: PubMed Medline
(January 1966 to April 2005), the Cochrane Library
(comprising the Database of Systematic Reviews [1988
to April 2005], Database of Abstracts on Reviews and
Effectiveness, and CENTRAL), National Research
Register [1988 to April 2005], Embase (January 1980
to April 2005) and two Chinese databases (Chinese
Journal Database and China Academic Journal from
1994 to 2004), including e-links to related articles. After
identifying relevant titles independently by two
authors (XWL and MMI), the corresponding abstracts
were read online. The full article was retrieved when
the information in the abstract appeared to meet the
inclusion criteria. A cross-reference search of the
eligible articles was performed to identify additional
studies not found in the computerised search.Study quality and data extraction
Two reviewers (XWL and MMI) independently
appraised each included article using a critical review
checklist of the Dutch Cochrane Centre and extracted
the data.32 The main points of this checklist are as
follows: (1) Clear definition of study population? (2)
Can selection bias be excluded sufficiently? (3) Clear
description of method of intervention? (4) Clear
definition of outcomes and outcome assessment? (5)
Independent assessment of outcome parameters? (6)
Sufficient duration of follow-up? (7) No selective loss
to follow-up? (8) Important confounders and prog-
nostic factors identified? Detailed study characteristics
were assessed and scored according to the proposals
of the Dutch Cochrane Centre and the checklist as
proposed by the meta-analysis of observational
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Venous Arterialization and Critical Ischaemia 495studies in epidemiology (Moose) group.30,32 Items for
which the studies have been scored are shown in
Table 3. We graded each item with a score of 0–3
depending on the available information, so that a
perfect study would have a maximum score of 36. Two
Chinese reviewers (Acknowledgements) helped to
appraise and extract data from Chinese articles. The
other authors (DAL and DTU) resolved any discre-
pancies (including study identification and data
extraction). The outcome parameters extracted were:
foot preservation, primary patency, secondary
patency, postoperative clinical improvement, compli-
cations and mortality.ResultsStudy descriptions
The search retrieved a total of 168 potentially relevant
studies. After the abstracts were screened for inclusion
criteria, 112 articles were excluded. Most studies were
excluded because the focus was on a different topic
(arteriovenous fistulas as adjunct to venous bypass
grafts, arteriovenous flow reversal on blood flow in
skin flaps, animal studies) or the article did not report
original research but was a commentary. Thus, 56
studies were selected for further review. On the basis
of the inclusion and exclusion criteria (inclusion of
patients with intermittent claudication, small number
of patients, short follow-up and duplicate reports),
another 49 articles had to be excluded. Finally, seven
articles fulfilled the inclusion criteria.19,21,24–26,28,29 The
characteristics of these studies are shown in Table 1.
Study sizes varied from 14 to 85 patients and
totalled 231 limbs in 228 patients. Four studies only
included patients with atherosclerosis obliterans.
Three studies included, beside atherosclerotic
patients, 91 patients with Buerger’s disease. Sub-
groups could not be identified because the treatment
results of Buerger’s disease were not given separately
from atherosclerosis obliterans in two studies.25,26 All
studies included patients with chronic CLI on the basis
of clinical symptoms, peripheral blood pressure
variables and angiographic findings. The proportion
of patients with ischaemic ulcers or/and gangrene
ranged from 28 to 87%
In all studies, patients underwent venous arterializa-
tions: in 4/7 studies the distal anastomosis was
performed at the level of the dorsal venous arch or a
vena comitans of the posterior tibial artery, usually with
destruction of the distal valves.19,21,24,25 The most distal
patent artery was used for inflow. Two studies reportedEur J Vasc Endovasc Surg Vol 31, May 2006
Table 2. Assessment of the quality of the seven included studies
Item Yes/No/?
Study
Taylor21 Matzke29 Ning25 Chen26 Courbier28 Lengua24 Pokrovsky19
Clear definition of study population? Yes Yes Yes Yes Yes Yes Yes
Can selection bias be excluded
sufficiently?
Yes ? Yes ? ? Yes Yes
Clear description of method of
intervention?
Yes Yes Yes Yes Yes Yes Yes
Clear definition of
outcomes and outcome assessment?
Yes ? Yes Yes ? Yes ?
Independent assessment of outcome
parameters?
No No No No No No No
Sufficient duration of follow-up? Yes Yes Yes Yes Yes Yes Yes
No selective loss to follow-up? Yes ? ? Yes Yes Yes ?
Important confounders and
prognostic factors identified?
Yes No Yes ? ? Yes ?
X. W. Lu et al.496the use of a sapheno-femoral shunt.28,29 In these patients
the great saphenous vein was directly anastomosed to
the femoral artery and the vein valves were destroyed.
All venous branches down to the ankle were ligated in
the distal venous arterialization study of Matzke et al.,29
but not in the study of Courbier et al.28 In the study of
Chen et al.26 primary distal or staged venous arterializa-
tionwas performed. In staged venous arterialization the
distal anastomosis is made with the deep vein or great
saphenous vein to form a temporary arteriovenous
fistula (AVF); a nylon thread that is simultaneously
placed around the proximal venous limbof theAVFwas
knotted and tied through the same incision 3–6 months
after the initial operation, converting the AVF into an
arteriovenous reversal. The distal valves were not
destroyed.26 Most of the studies report additional
minor local surgery, such as toe amputations, debride-
ment and skin grafting.
All authors used foot preservation (major amputation
rate after 12 months) as the primary endpoint. In all
papers amajor amputationwasdefinedasanamputation
at foot level or higher. Secondary patency was describedTable 3. Study characteristics regarding descriptions of patients and
Taylor 21 Matzke29 Nin
Operative reasons 3 3 3
Previous treatment 3 1 3
Clinical characteristics 3 3 3
Operative determinant 3 1 2
Operative procedure 3 3 3
FP and SP or PP 3 3 3
Postoperative complications 3 0 2
Objective assessment of blood flow 0 0 3
Clinical improvement 3 0 3
Postoperative therapy 1 0 0
Mortality 3 3 2
Loss to follow-up 3 1 1
Total scores 31 18 28
Adequate, 3 points; fair, 2 points; poor, 1 point; no description, 0 point
Eur J Vasc Endovasc Surg Vol 31, May 2006in most of the studies, but primary patency only in a few
and, therefore, not considered in our further analysis.
Most authors described postoperative clinical improve-
ment, all-causemortality andcomplications, butobjective
postoperative assessment of lower limb blood flow was
described in only a few studies.Study quality
Six studies were clinical observational studies; one
was a controlled retrospective comparative study.29
Most studies had a reasonable quality (Table 2), in
particular those of Taylor et al. and Lengua et al.21,24
The mean study characteristics score of the included
seven articles was 25 (range 18–31, Table 3).Outcome variablesFoot preservation
In the various studies, FP ranged from 47 to 82%. The
1-year FP was described in four articles, being 80, 75,outcomes
g25 Chen 26 Courbier 28 Lengua 24 Pokrovsky 19
3 3 3 3
1 0 3 1
2 2 3 3
3 2 3 3
3 3 3 3
2 2 2 3
2 2 3 2
0 0 0 1
3 2 2 2
1 1 3 1
3 3 3 3
0 0 3 0
23 20 31 23
s.
Venous Arterialization and Critical Ischaemia 49760 and 57%.19,21,24,29 This results in an overall
weighted mean of 71% (95% CI: 64–77%). Ning et al.
reported a FP of 82% after a follow-up of 1–10 years.25
Chen et al. described a limb salvage rate of 75% at 27
months of follow-up,26 and Courbier et al.mentioned a
salvage rate of 47% after 17 months.28
Secondary graft patency
SP better reflects the fate of venous arterialization
grafts and usually was described more precisely than
the primary patency. SP was described at 1-year
follow-up in four studies, being 34, 72, 48, and 78%,
respectively.19,21,24,29 This results in an overall
weighted mean of 46% (95% CI: 39–53%). Ning et al.
reported a SP of 76% after a follow-up of 1–10 years.25
Postoperative clinical improvement
During follow-up the patients without amputation, it
was noted that the largemajority of the wounds healed
successfully and rest pain had resolved. Patients also
reported a significant increase in walking distance.
However, most studies missed objective assessment of
leg blood flow during follow-up, such as measure-
ments of ankle-brachial pressure index and treadmill
exercise, toe pressures and transcutaneous oxygen
tension (TcpO2). One study showed a mean increase in
transcutaneous oxygenation pressures of 1.6 kPa (i.e.
12 mmHg).25
Postoperative complications and mortality
Postoperative oedema was the most common compli-
cation, occurring in nearly all patients, but this
generally disappeared after 5–30 days and persisted
in a few patients only. In one study, one patient
suffered from cardiac insufficiency and, as a conse-
quence, the sapheno-femoral shunt had to be ligated
and the affected limb amputated.28 In the study of
Pokrovsky et al. four patients with Buerger’s disease
suffered from venous gangrene and the affected limb
had to be amputated.19 Other complications were
similar to those for arterial bypass surgery at long-
term follow-up. Mortality rate during follow-up was
1–33%. None of the deaths were reported to be related
to the reversed venous circulation.Discussion
Our systematic review found few, predominantly
uncontrolled studies, which suggest that venous
arterialization can successfully salvage the critically
ischaemic lower limb with few serious complications.
Due to the lack of prospectively controlled trials, case
series (observational studies) were the only targets forour meta-analysis. We emphasize that variability
among surgeons and patients at different centres in
different countries challenge the validity of our review.
Accordingly, the diversity of study characteristics asks
for a careful interpretation. However, observational
studies do play an important role when dealing with a
well-defined problem, for example in rare or severe
disease or the use of poorly effective techniques.30
Venous arterialization for critical limb ischaemia is one
such a problem. Included patients could not be
revascularized with the conventional methods and
are at high risk of amputation had nothing been done.
Furthermore, all studies included here focused on
limb salvage, clinical improvement and complications.
Publication bias could have skewed our results as only
papers with positive results tend to be published, but
this form of bias is a recurring problem with analysis
of non-randomized studies.
The crucial outcome is whether venous arteriali-
zation is effective. Foot preservation usually was
described precisely; therefore, this parameter is a
natural target for meta-analyses aiming to assess
outcomes of venous arterialization. The results in our
analysis are encouraging, with an overall foot preser-
vation of 71% (95% CI: 64–77%) at 1-year follow-up
and a FP rate of over 75% after at least 1-year of follow-
up in two other studies.25,26 Furthermore, the patients
saved from major amputation experienced wounds
healed successfully, rest pain that resolved and
increasing walking distance. This appears better than
the treatment with prostaglandins or spinal cord
stimulation.33 Recently, some reports of venous
arterialization were published, which have not
been included in our study because of small numbers
or/and a follow-up of less than 1 year. All of these
showed acceptable FP rates, which corroborate our
conclusion.15,17,18
In most of the seven included studies distal venous
arterializations with destruction of the distal valves
was the preferred technique.19,21,24,25,29 In 1975,
Lengua et al. from France introduced the concept of a
more distal anastomosis,34 which resulted in a better
outcome.19,21–24 After that time an increasing number
of surgeons gradually recognized and emphasized
two important technical points to improve results: a
more distal localization of the arteriovenous anasto-
mosis and the destruction of the valves in veins
distally to the site of the distal anastomosis, including
the valves in foot veins.14,15,17,19,21,24,25 Distal venous
valves are present in most people; their destruction is
logical when reversal of flow is the aim of venous
arterialisation. Since then, clinical reports showed
improved outcomes and distal venous arterializationsEur J Vasc Endovasc Surg Vol 31, May 2006
X. W. Lu et al.498with destruction of the distal valves have become the
main operative option.
Different techniques to destroy the valves have been
described. Pokrovsky et al. described direct valvulect-
omy at the site of the distal anastomosis in the opened
venous arch and passage of metallic olives into the
distal part of the arch to destroy the valves.19 Taylor et
al. suggest destroying the valves by retrograde balloon
disruption and passage of so called ‘Parronnet’
probes.21 When difficulties arise with the retrograde
passage of a Fogarty catheter, Rowe et al. found that
the passage of a guidewire (0.018 or 0.035 mm) was
helpful.17
Disappointing results for FP were found in two
series (47 and 57%).28,29 These two studies had the
lowest study quality and study characteristics scores.
In the early study from 1973 of Courbier et al.
arteriovenous arterialization was performed at the
level of the groin, the branches of the saphenous vein
were not ligated and the authors did not clearly
mention the destruction of venous valves at the level
of the foot.28 The other study from Matzke et al. was a
controlled, comparative study. Fifty percent of the
lower limb amputations were performed with a patent
graft and four patients were revascularised by
conventional bypass surgery after initial failure of
venous arterialization.29
It is purported that the highly pulsatile pressure
generated by means of primary or staged venous
arterialization can destroy distal venous valves and
improve perfusion of critically ischaemic tissues.26
This aspect is supported by a recent article,18 but
whether or not highly pulsatile pressure can destroy
distal venous valves remains controversial.
Secondary patency was 46% at 1-year of follow-up
and was worse than the foot preservation rate (a mean
difference of 25%). The difference between foot
preservation and secondary patency reflects the
specific effect of venous arterialization. The precise
mechanism for this effect remains unknown, but it has
been ascribed to various angiogenic growth factors
released in an ischaemic environment that provide
neovascularisation, in combination with the develop-
ment of collaterals.7–10 This mechanism might explain
why grafts that fail after more than a few months do
not generally lead to amputation, an observation that
is clearly clinically important.
Few serious postoperative complications were
reported in the included studies; the most common
complication was lower limb oedema. In one early
study, one patient suffered from cardiac insufficiency
because of excessive arteriovenous shunting.28 A more
distal anastomosis might reduce the risk of oedema
and heart failure as a result of less shunting. In anotherEur J Vasc Endovasc Surg Vol 31, May 2006study, there were four patients (all Buerger’s disease)
who suffered from venous gangrene, which seemed to
be related to the patients damaged venous system as a
result of migrating thrombophlebitis.19 Perioperative
mortality was low, although in most series a consider-
able number of patients died during follow-up, which
is hardly surprising in a population of patients with
critical limb ischaemia.
Three studies included patients with Buerger’s
disease.19,25,26 Although long-term graft patency was
poor, a limb salvage rate of 68% could be achieved in
one large series.19 It is well known that bypass surgery
in patients with Buerger’s disease has a lower graft
patency as compared with bypass surgery in athero-
sclerotic patients.35 Nevertheless, patients with Buer-
ger’s disease showed a good FP rate with venous
arterialization.11,12,17 Rowe et al. reported two patients
(three limbs) with Buerger’s disease in whom distal
venous arterialization was performed. Despite early
graft problems all three limbs could be saved.17
In conclusion, this systematic review shows that
few studies have been performed on venous arter-
ialization for ‘inoperable’ leg ischaemia. The available
evidence suggests that venous arterialization may
successfully result in salvage of otherwise unsalvage-
able legs without serious complications. However,
uncertainties do remain, and improvements in surgi-
cal techniques are needed. At present, no consensus
consists on the optimal operative procedure. Given the
small number of series and patients in this systematic
review, further clinical trials of this technique are
necessary to convince the vascular specialist of its
benefits.Acknowledgements
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